CVE-2026-123014
iTerm2 before 3.7.7beta2 has an argument injection vulnerability in the x-man-page: URL handler, allowing an attacker to execute arbitrary commands with the privileges of the logged-in user by inducing the user to open a crafted URL in iTerm2. Percent-encoded NUL characters survive input sanitization and are subsequently converted to whitespace during command-line parsing, allowing injection of additional arguments to /usr/bin/man. An attacker can inject the -P option to select an attacker-controlled pager command. NOTE: this issue exists because of an incomplete fix for CVE-2023-46321.
Executive briefing
The source record describes: iTerm2 before 3.7.7beta2 has an argument injection vulnerability in the x-man-page: URL handler, allowing an attacker to execute arbitrary commands with the privileges of the logged-in user by inducing the user to open a crafted URL in iTerm2. Percent-encoded NUL characters survive input sanitization and are subsequently converted to whitespace during command-line parsing, allowing injection of additional arguments to /usr/bin/man. An attacker can inject the -P option to select an attacker-controlled pager command. NOTE: this issue exists because of an incomplete fix for CVE-2023-46321. The practical risk depends on whether an affected product/version is present, reachable and configured in an exploitable way. Review the affected-product evidence and linked vendor advisories before assigning exposure status.
Evidence confidence: Limited Evidence-derived, not an exploitability verdict
Severity & attack characteristics
CVSS vector:CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Technical explanation & impact
The technical mechanism is not expanded beyond the source description unless a referenced advisory supplies additional evidence. Read the linked vendor/CERT advisories for root-cause detail.
Potential impact must be interpreted from the published CVSS impact metrics and the affected component. A CVSS impact score is not proof that a particular asset is exploitable.
Weakness classification
CWE-88Affected products and versions
NVD has not supplied machine-readable vulnerable CPE product/version entries for this CVE. This is an information gap, not proof that no products are affected. Check the vendor advisory references below.
Remediation & validation
- Identify exposure by comparing the affected product and version ranges with your asset inventory, SBOM and externally exposed services.
- Review the linked vendor security advisory or patch notes. Upgrade to a vendor-confirmed fixed release; do not infer a fixed version from the CVE description.
- Until patched, consider restricting network access or disabling the affected feature where operationally safe. These are temporary controls, not a substitute for a vendor fix.
- Validate the remediation with a version check and vulnerability rescan, then retain change evidence.
No fixed version is displayed unless it is explicitly established by a vendor advisory. Follow the vendor's release notes for exact product and branch applicability.
Vendor advisories, patches & exploit references
- https://gitlab.com/gnachman/iterm2/-/commit/314ba43920dbce08808c032e89966918090bdf8e REFERENCE cve@mitre.org
- https://gitlab.com/gnachman/iterm2/-/commit/f29420ae4d3e0f986ee24ea286885d32af58175a VENDOR cve@mitre.org
- https://iterm2.com/downloads.html REFERENCE cve@mitre.org
Information gaps & confidence notes
These gaps indicate missing source data. CVE Watch does not fill them with guessed product, exploit or patch details.
- NVD does not currently provide machine-readable vulnerable CPE product/version entries for this record.
Last enrichment: 2026-11-06T07:47:25+00:00 · Source last modified: 2026-11-05T06:17:07.707